gatifloxacin has been researched along with Haemophilus Infections in 5 studies
Gatifloxacin: A fluoroquinolone antibacterial agent and DNA TOPOISOMERASE II inhibitor that is used as an ophthalmic solution for the treatment of BACTERIAL CONJUNCTIVITIS.
gatifloxacin : A monocarboxylic acid that is 4-oxo-1,4-dihydroquinoline-3-carboxylic acid which is substituted on the nitrogen by a cyclopropyl group and at positions 6, 7, and 8 by fluoro, 3-methylpiperazin-1-yl, and methoxy groups, respectively. Gatifloxacin is an antibiotic of the fourth-generation fluoroquinolone family, that like other members of that family, inhibits the bacterial topoisomerase type-II enzymes.
Haemophilus Infections: Infections with bacteria of the genus HAEMOPHILUS.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To compare gatifloxacin with amoxicillin/clavulanate in children with recurrent or nonresponsive acute otitis media (AOM)." | 9.11 | Randomized, investigator-blinded, multicenter study of gatifloxacin versus amoxicillin/clavulanate treatment of recurrent and nonresponsive otitis media in children. ( Arguedas, A; Echols, R; Hamed, KA; Pierce, P; Rodriguez, A; Sáez-Llorens, X; Yang, J, 2005) |
| "To compare the clinical efficacy of gatifloxacin with amoxicillin/clavulanate for the treatment of acute otitis media treatment failure and recurrent otitis media." | 9.11 | Randomized, investigator-blinded, multicenter, comparative study of gatifloxacin versus amoxicillin/clavulanate in recurrent otitis media and acute otitis media treatment failure in children. ( Arguedas, A; Biswas, D; Echols, R; Hamed, KA; Husseman, M; Pichichero, M; Pierce, P; Sher, L, 2005) |
| "In this community-based safety surveillance study, the advanced-generation fluoroquinolone gatifloxacin was administered empirically to 15625 adults with community-acquired respiratory tract infections (RTIs), including 1562 clinically evaluable patients with community-acquired pneumonia (CAP) and 2391 with acute exacerbations of chronic bronchitis (AECB)." | 9.10 | Haemophilus influenzae in respiratory tract infections in community-based clinical practice: therapy with gatifloxacin. ( Andriole, VT; Jones, RN; Nicholson, SC; Webb, CD; Wilson, WR, 2002) |
| "To compare gatifloxacin with amoxicillin/clavulanate in children with recurrent or nonresponsive acute otitis media (AOM)." | 5.11 | Randomized, investigator-blinded, multicenter study of gatifloxacin versus amoxicillin/clavulanate treatment of recurrent and nonresponsive otitis media in children. ( Arguedas, A; Echols, R; Hamed, KA; Pierce, P; Rodriguez, A; Sáez-Llorens, X; Yang, J, 2005) |
| "To compare the clinical efficacy of gatifloxacin with amoxicillin/clavulanate for the treatment of acute otitis media treatment failure and recurrent otitis media." | 5.11 | Randomized, investigator-blinded, multicenter, comparative study of gatifloxacin versus amoxicillin/clavulanate in recurrent otitis media and acute otitis media treatment failure in children. ( Arguedas, A; Biswas, D; Echols, R; Hamed, KA; Husseman, M; Pichichero, M; Pierce, P; Sher, L, 2005) |
| "In this community-based safety surveillance study, the advanced-generation fluoroquinolone gatifloxacin was administered empirically to 15625 adults with community-acquired respiratory tract infections (RTIs), including 1562 clinically evaluable patients with community-acquired pneumonia (CAP) and 2391 with acute exacerbations of chronic bronchitis (AECB)." | 5.10 | Haemophilus influenzae in respiratory tract infections in community-based clinical practice: therapy with gatifloxacin. ( Andriole, VT; Jones, RN; Nicholson, SC; Webb, CD; Wilson, WR, 2002) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (80.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Proksch, JW | 1 |
| Ward, KW | 1 |
| Nicholson, SC | 1 |
| Webb, CD | 1 |
| Andriole, VT | 1 |
| Jones, RN | 1 |
| Wilson, WR | 1 |
| Dagan, R | 1 |
| Arguedas, A | 3 |
| Schaad, UB | 1 |
| Sáez-Llorens, X | 1 |
| Rodriguez, A | 1 |
| Hamed, KA | 2 |
| Yang, J | 1 |
| Pierce, P | 2 |
| Echols, R | 2 |
| Sher, L | 1 |
| Husseman, M | 1 |
| Pichichero, M | 1 |
| Biswas, D | 1 |
1 review available for gatifloxacin and Haemophilus Infections
| Article | Year |
|---|---|
Potential role of fluoroquinolone therapy in childhood otitis media.
Topics: Anti-Infective Agents; Child; Child, Preschool; Drug Resistance, Microbial; Fluoroquinolones; Gatifl | 2004 |
3 trials available for gatifloxacin and Haemophilus Infections
| Article | Year |
|---|---|
Haemophilus influenzae in respiratory tract infections in community-based clinical practice: therapy with gatifloxacin.
Topics: Administration, Oral; Anti-Infective Agents; Community-Acquired Infections; Dose-Response Relationsh | 2002 |
Randomized, investigator-blinded, multicenter study of gatifloxacin versus amoxicillin/clavulanate treatment of recurrent and nonresponsive otitis media in children.
Topics: Amoxicillin-Potassium Clavulanate Combination; Anti-Infective Agents; Child; Child, Preschool; Femal | 2005 |
Randomized, investigator-blinded, multicenter, comparative study of gatifloxacin versus amoxicillin/clavulanate in recurrent otitis media and acute otitis media treatment failure in children.
Topics: Acute Disease; Amoxicillin-Potassium Clavulanate Combination; Anti-Infective Agents; Child; Child, P | 2005 |
1 other study available for gatifloxacin and Haemophilus Infections
| Article | Year |
|---|---|
Ocular pharmacokinetics/pharmacodynamics of besifloxacin, moxifloxacin, and gatifloxacin following topical administration to pigmented rabbits.
Topics: Administration, Topical; Animals; Aqueous Humor; Area Under Curve; Aza Compounds; Azepines; Conjunct | 2010 |